RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Hypertriglyceridemia
Accession: DOID:9006599
browse the term
Definition: A condition of elevated levels of TRIGLYCERIDES in the blood.
Synonyms: exact_synonym: Hypertriglyceridemias
related_synonym: Hypertriglyceridemia, Susceptibility To
primary_id: MESH:D015228
xref: EFO:0004211
G
Acaca
acetyl-CoA carboxylase alpha
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acacb
acetyl-CoA carboxylase beta
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
G
Acot1
acyl-CoA thioesterase 1
treatment
IDA
RGD
PMID:23994635
RGD:13831127
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
G
Acp1
acid phosphatase 1
ISO
associated with Obesity
RGD
PMID:12409270
RGD:1625288
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
G
Ada
adenosine deaminase
treatment
IEP
RGD
PMID:30280312
RGD:152995395
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
associated with HIV Infections
RGD
PMID:21595566
RGD:8694463
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adrb2
adrenoceptor beta 2
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Ahr
aryl hydrocarbon receptor
treatment
IEP
RGD
PMID:23644946
RGD:401794573
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ahsg
alpha-2-HS-glycoprotein
ISO
protein:increased expression:serum
RGD
PMID:19228823
RGD:2313809
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32045588
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Angptl3
angiopoietin-like 3
ISO
RGD
PMID:12672813
RGD:1578347
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
G
Angptl4
angiopoietin-like 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28842503
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Apoa1
apolipoprotein A1
no_association treatment
ISO IEP
DNA:polymorphism:promoter:-75G>A
RGD
PMID:7910586 PMID:23644946
RGD:1601187 , RGD:401794573
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apoa2
apolipoprotein A2
ISO
DNA:polymorphism
RGD
PMID:9489233
RGD:1601190
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
G
Apoa4
apolipoprotein A4
ISO
human gene in mouse model
RGD
PMID:2167514
RGD:5685672
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Apoa5
apolipoprotein A5
IEP ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism: :-1131T>C (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hypertriglyceridemia
CTD ClinVar RGD
PMID:18324930 PMID:19447388 PMID:20657596 PMID:23151256 PMID:23307945 PMID:24591733 PMID:24793350 PMID:25487149 PMID:25741868 PMID:27108409 PMID:28492532 PMID:32041611 PMID:16238453 PMID:18468520 PMID:12818421 More...
RGD:2313328 , RGD:2313317 , RGD:1578414
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Apob
apolipoprotein B
IEP ISO
protein:increased expression:plasma (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20657596 PMID:8121310
RGD:11353966
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoc1
apolipoprotein C1
ISO
protein:increased expression:plasma
RGD
PMID:3757210
RGD:2313953
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
G
Apoc2
apolipoprotein C2
susceptibility
ISO
RGD
PMID:3944267 PMID:7590197
RGD:1601214 , RGD:1601205
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Apoc3
apolipoprotein C3
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent or Coronary Disease;DNA:polymorphism
RGD
PMID:7705829 PMID:15715433
RGD:1578444 , RGD:2306767
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
Apoe
apolipoprotein E
susceptibility
ISO IMP
associated with Metabolic Syndrome X; DNA:missense mutations:cds:p.C112R, p.R158C (human)
RGD GAD
PMID:15713714 PMID:15118671 PMID:28808185
RGD:1601235 , RGD:1331525 , RGD:13703132
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Bche
butyrylcholinesterase
ISO
associated with diabetes mellitus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23000450 PMID:8149699
RGD:1601335
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Cela2a
chymotrypsin like elastase 2A
ISO
ClinVar Annotator: match by term: Hypertriglyceridemia
ClinVar
PMID:25741868 PMID:31358993
NCBI chr 5:154,126,879...154,136,630
Ensembl chr 5:154,126,878...154,136,632
G
Cftr
CF transmembrane conductance regulator
ISO
associated with Pancreatitis;DNA:missense mutation, haplotype: :p.I556V (human)
RGD
PMID:17981921
RGD:11566035
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Crp
C-reactive protein
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11893366
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
treatment
IEP
RGD
PMID:23644946
RGD:401794573
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Dgat1
diacylglycerol O-acyltransferase 1
treatment
ISO
RGD
PMID:18183944
RGD:10401058
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
G
Dgat2
diacylglycerol O-acyltransferase 2
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
F7
coagulation factor VII
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:plasma (human)
RGD
PMID:19329212
RGD:2312379
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Fabp2
fatty acid binding protein 2
ISO
associated with Diabetes Mellitus, Type 2;DNA:missense mutation:cds:p.A54T (human)
RGD
PMID:16919542 PMID:10999802
RGD:1626401 , RGD:1300313
NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
G
Fasn
fatty acid synthase
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
G6pd
glucose-6-phosphate dehydrogenase
treatment
IEP
RGD
PMID:22947172
RGD:10449176
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gckr
glucokinase regulator
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hypertriglyceridemia DNA:SNPs,haplotypes: (rs780094) (human)
CTD ClinVar RGD
PMID:20657596 PMID:22182842 PMID:25741868 PMID:28492532 PMID:27599772
RGD:401794577
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
G
Gfpt1
glutamine fructose-6-phosphate transaminase 1
ISO
RGD
PMID:11118009
RGD:1625423
NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Gpr55
G protein-coupled receptor 55
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30148676
NCBI chr 9:86,584,906...86,640,601
Ensembl chr 9:86,590,885...86,640,613
G
Gpx3
glutathione peroxidase 3
ISO
associated with coronary artery disease;DNA:SNP: :rs3828599 (human)
RGD
PMID:31396447
RGD:401827159
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Hnf4a
hepatocyte nuclear factor 4, alpha
ISO
RGD
PMID:16804065
RGD:1601642
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Il6st
interleukin 6 cytokine family signal transducer
IDA
RGD
PMID:8843746
RGD:1626687
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Ins2
insulin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12754275
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Insig1
insulin induced gene 1
severity
ISO
associated with Obesity
RGD
PMID:15096598
RGD:2308857
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Insig2
insulin induced gene 2
severity
ISO
associated with Obesity
RGD
PMID:15096598
RGD:2308857
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Lamc1
laminin subunit gamma 1
susceptibility
ISO
DNA:SNPs,haplotypes: (rs10911205) (human)
RGD
PMID:27599772
RGD:401794577
NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492
G
Lcat
lecithin cholesterol acyltransferase
ISO
RGD
PMID:14668345
RGD:1581782
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Ldlr
low density lipoprotein receptor
IMP
RGD
PMID:28469073 PMID:27378433
RGD:12910100 , RGD:12910104
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Ldlrem1
low density lipoprotein receptor; ZFN induced mutant 1
IMP
RGD
PMID:27378433
RGD:12910104
G
Ldlrem1Sage
low density lipoprotein receptor; ZFN induced mutant 1, Sage
IMP
RGD
PMID:28469073
RGD:12910100
G
Lep
leptin
IMP
RGD
PMID:22948215
RGD:12904911
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lepem1Sage
leptin; zinc finger nuclease induced mutant1, Sage
IMP
RGD
PMID:22948215
RGD:12904911
G
Lipc
lipase C, hepatic type
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased expression:plasma (human)
RGD
PMID:187516
RGD:2308846
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
G
Lipe
lipase E, hormone sensitive type
IDA
RGD
PMID:11016888
RGD:2313581
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
G
Lipi
lipase I
susceptibility
ISO
DNA:polymorphism: :p.C55Y
RGD
PMID:12719377
RGD:1625450
NCBI chr11:14,189,323...14,228,992
Ensembl chr11:14,189,323...14,228,985
G
Lmf1
lipase maturation factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17994020
NCBI chr10:14,597,726...14,684,071
Ensembl chr10:14,597,594...14,684,119
G
Lpl
lipoprotein lipase
susceptibility
IDA ISO
CTD Direct Evidence: marker/mechanism|therapeutic ClinVar Annotator: match by term: Hypertriglyceridemia
CTD ClinVar RGD
PMID:8147947 PMID:20657596 PMID:25741868 PMID:11016888 PMID:16431216 PMID:17848837 More...
RGD:2313581 , RGD:1580533 , RGD:2313305
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrp1b
LDL receptor related protein 1B
treatment
HDA
RGD
PMID:30905023
RGD:151665141
NCBI chr 3:24,594,302...26,715,037
Ensembl chr 3:24,594,991...26,715,505
G
Lta
lymphotoxin alpha
susceptibility no_association
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent DNA:polymorphism
RGD
PMID:7783649 PMID:9245742
RGD:1625036 , RGD:1625035
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32045588
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mlxipl
MLX interacting protein-like
treatment susceptibility
IEP ISO
DNA:SNPs,haplotypes: (rs17145738) (human)
RGD
PMID:26394137 PMID:27599772
RGD:329955565 , RGD:401794577
NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
G
Mlycd
malonyl-CoA decarboxylase
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr19:47,447,931...47,463,794
Ensembl chr19:47,447,970...47,463,793
G
Mtor
mechanistic target of rapamycin kinase
IMP
associated with Insulin Resistance
RGD
PMID:20566415
RGD:10040984
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Ndufb6
NADH:ubiquinone oxidoreductase subunit B6
IEP
associated with obesity
RGD
PMID:20729114
RGD:13801195
NCBI chr 5:55,400,543...55,410,110
Ensembl chr 5:55,400,543...55,410,181
G
Nos3
nitric oxide synthase 3
IEP
protein:decreased expression:aorta
RGD
PMID:17824809
RGD:2292131
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
IMP
compared to FHH
RGD
PMID:24722447
RGD:12910103
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a1m1Mcwi
nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin
IMP
compared to FHH
RGD
PMID:24722447
RGD:12910103
G
Pde5a
phosphodiesterase 5A
IMP
RGD
PMID:18787522
RGD:2314464
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
G
Pklr
pyruvate kinase L/R
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
G
Plin2
perilipin 2
ISO
associated with Obesity
RGD
PMID:17484887
RGD:1625752
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Pltp
phospholipid transfer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12754275
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
G
Pon1
paraoxonase 1
treatment
IEP
RGD
PMID:23644946
RGD:401794573
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15309680
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppargc1a
PPARG coactivator 1 alpha
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppargc1b
PPARG coactivator 1 beta
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr18:54,758,891...54,861,103
Ensembl chr18:54,758,902...54,861,194
G
Rbp4
retinol binding protein 4
ISO
protein:increased expression:blood serum (human)
RGD
PMID:29747616
RGD:329849113
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
G
Rps12
ribosomal protein S12
IEP
associated with Metabolic Syndrome X;mRNA:increased expression:liver
RGD
PMID:25294893
RGD:11039460
NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014
G
Scd
stearoyl-CoA desaturase
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Serpinf2
serpin family F member 2
ISO
protein:increased expression:plasma
RGD
PMID:9207984
RGD:1625533
NCBI chr10:60,272,400...60,280,506
Ensembl chr10:60,272,400...60,281,243
G
Socs1
suppressor of cytokine signaling 1
ISO
associated with Obesity
RGD
PMID:15240880
RGD:1625677
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs3
suppressor of cytokine signaling 3
ISO
associated with Obesity
RGD
PMID:15240880
RGD:1625677
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
ISO
associated with coronary artery disease;DNA:SNP: :rs4880 (human)
RGD
PMID:31396447
RGD:401827159
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
ISO
associated with coronary artery disease;DNA:SNP: :rs2536512, rs2855262 (human)
RGD
PMID:31396447
RGD:401827159
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Srebf1
sterol regulatory element binding transcription factor 1
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Trib1
tribbles pseudokinase 1
susceptibility
ISO
DNA:SNPs,haplotypes: (rs6982502) (human)
RGD
PMID:27599772
RGD:401794577
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
G
Trpm1
transient receptor potential cation channel, subfamily M, member 1
ISO
DNA:SNP:intron:g.59080C>T (rs11070811) (human)
RGD
PMID:21439949
RGD:7175561
NCBI chr 1:117,718,896...117,835,434
Ensembl chr 1:117,718,896...117,834,605
G
Txnip
thioredoxin interacting protein
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP:3' utr
RGD
PMID:17381501
RGD:1642750
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Vldlr
very low density lipoprotein receptor
IEP
associated with Kidney Failure, Chronic;mRNA, protein:decreased expression:adipose tissue, skeletal muscle
RGD
PMID:9507207
RGD:1625577
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Xbp1
X-box binding protein 1
treatment
IEP
RGD
PMID:26394137
RGD:329955565
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Apoa5
apolipoprotein A5
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Apoa5
apolipoprotein A5
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Familial type 5 hyperlipoproteinemia
CTD OMIM ClinVar
PMID:12417524 PMID:12417525 PMID:16200213 PMID:16806135 PMID:18324930 PMID:19447388 PMID:21993410 PMID:23151256 PMID:23307945 PMID:24591733 PMID:24793350 PMID:25487149 PMID:25741868 PMID:27108409 PMID:27578109 PMID:27678447 PMID:28492532 PMID:28951076 PMID:29954705 PMID:31619059 PMID:31980526 PMID:32041611 PMID:33111339 PMID:36325899 More...
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Apoa5
apolipoprotein A5
ISO
ClinVar Annotator: match by term: Hypertriglyceridemia 1
ClinVar OMIM
PMID:11588264 PMID:12417524 PMID:12417525 PMID:12915450 PMID:18324930 PMID:18635818 PMID:19447388 PMID:20657596 PMID:23151256 PMID:23307945 PMID:24387992 PMID:24591733 PMID:24793350 PMID:25127531 PMID:25487149 PMID:25741868 PMID:27108409 PMID:28492532 PMID:29954705 PMID:31980526 PMID:32041611 PMID:36325899 More...
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Creb3l3
cAMP responsive element binding protein 3-like 3
ISO
ClinVar Annotator: match by term: Hypertriglyceridemia 1
ClinVar
PMID:21666694 PMID:25741868 PMID:26046366 PMID:28492532 PMID:31619059 PMID:32041611 PMID:36325899 PMID:37940981 More...
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Lipi
lipase I
ISO
ClinVar Annotator: match by term: Hypertriglyceridemia 1
ClinVar
PMID:12719377 PMID:25741868 PMID:28492532
NCBI chr11:14,189,323...14,228,992
Ensembl chr11:14,189,323...14,228,985
G
Rp1
RP1, axonemal microtubule associated
ISO
ClinVar Annotator: match by term: Hypertriglyceridemia 1
ClinVar
PMID:12764676 PMID:20664799 PMID:25741868 PMID:28492532
NCBI chr 5:15,121,104...15,582,363
Ensembl chr 5:15,121,133...15,579,363
G
Zpr1
ZPR1 zinc finger
ISO
ClinVar Annotator: match by term: Hypertriglyceridemia 1
ClinVar
PMID:25741868
NCBI chr 8:46,564,898...46,574,719
Ensembl chr 8:46,565,146...46,574,719
G
Creb3l3
cAMP responsive element binding protein 3-like 3
ISO
ClinVar Annotator: match by term: Hypertriglyceridemia 2
OMIM ClinVar
PMID:21666694 PMID:25741868 PMID:26046366 PMID:26427795 PMID:28492532 PMID:32041611 PMID:36325899 PMID:37940981 More...
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
ISO
ClinVar Annotator: match by term: GPD1-related condition | ClinVar Annotator: match by term: Hypertriglyceridemia, transient infantile
OMIM ClinVar
PMID:22226083 PMID:24549054 PMID:25741868 PMID:27368975 PMID:28492532 PMID:32591995 PMID:32685347 More...
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all